Internal Medicine · Long Beach, CA
NPI
1366481384
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1045 Atlantic Ave, Suite 505
Long Beach, CA, 90813
Phone (562) 495-4952
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
2,255 services
Medicare patients, 2024
269
Average age 76
Drug cost, 2024
$898K
8,909 prescriptions
Company payments, 2025
$588
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter Ferrera was code 99233 (hospital e&m - subsequent), 345 times for 44 patients. In total Peter Ferrera billed 2,255 services in 52 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 345 | 44 | $97.09 | $33K |
| 99214 Office E&M - Established | Office | 324 | 170 | $103.69 | $34K |
| 99232 Hospital E&M - Subsequent | Facility | 208 | 21 | $64.96 | $14K |
| 36415 Venipuncture Blood Collection | Office | 172 | 123 | $8.65 | $1,488 |
| 96372 Injection Administration | Office | 114 | 45 | $11.48 | $1,308 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 112 | 44 | $0.89 | $99.31 |
| 99309 SNF E&M | Facility | 96 | 22 | $90.48 | $8,686 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 87 | 87 | $140.51 | $12K |
| 93000 Electrocardiogram | Office | 85 | 81 | $12.12 | $1,030 |
| 99213 Office E&M - Established | Office | 68 | 53 | $66.88 | $4,548 |
| G0008 Administration of influenza virus vaccine | Office | 65 | 65 | $35.02 | $2,276 |
| 90653 Vaccine Product | Office | 61 | 61 | $81.82 | $4,991 |
| 99239 Hospital Discharge Management | Facility | 61 | 42 | $95.12 | $5,802 |
| 99308 SNF E&M | Facility | 61 | 12 | $62.69 | $3,824 |
| 99223 Hospital E&M - Initial | Facility | 59 | 38 | $142.54 | $8,410 |
By year: 2022 $240K for 5,573 services; 2023 $224K for 3,520 services; 2024 $165K for 2,255 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 172 | 123 | $8.65 | $1,488 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter Ferrera prescribed most often to Medicare patients was Atorvastatin Calcium, with 571 prescriptions and refills. In total Peter Ferrera wrote 8,909 Medicare prescriptions that cost $898K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 571 | 1,392 | 160 | $5,517 |
| Amlodipine Besylate Generic | 541 | 1,359 | 156 | $3,689 |
| Metformin Hcl Generic | 300 | 659 | 83 | $1,794 |
| Losartan Potassium Generic | 285 | 722 | 86 | $2,386 |
| Levothyroxine Sodium Generic | 265 | 647 | 77 | $3,699 |
| Pantoprazole Sodium Generic | 242 | 546 | 70 | $3,619 |
| Metoprolol Succinate Generic | 227 | 542 | 59 | $3,730 |
| Lisinopril Generic | 215 | 548 | 58 | $1,495 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 198 | 198 | 53 | $4,151 |
| Eliquis Apixaban | 183 | 283 | 34 | $137K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 179 | 228 | 50 | $5,076 |
| Tamsulosin Hcl Generic | 179 | 400 | 50 | $2,414 |
| Gabapentin Generic | 157 | 268 | 45 | $3,535 |
| Simvastatin Generic | 144 | 323 | 34 | $958 |
| Furosemide Generic | 139 | 298 | 42 | $800 |
Brand drugs: 1,162 claims; generic drugs: 7,695 claims; opioid claims: 278.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter Ferrera $588 ($588 in general payments such as food, travel and fees) from 10 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $142.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $142 |
| GlaxoSmithKline, LLC. GSK | 4 | $106 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $103 |
| Lilly USA, LLC LLY | 3 | $74.36 |
| Pfizer Inc. PFE | 2 | $40.17 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $33.53 |
| Amgen Inc. AMGN | 1 | $27.35 |
| Merck Sharp & Dohme LLC MRK | 1 | $21.16 |
| Exact Sciences Corporation EXAS | 1 | $20.96 |
| Viatris Specialty LLC | 1 | $18.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.